We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
SWISS LAW AND TAX
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
In the VISCHER Innovation Lab, we not only work in the field of law, we also develop our solutions ourselves as far as possible from a technical point of view.
VISCHER Legal Innovation Lab
Red Ink
Careers
Ikerian, a healthcare software platform company that organizes multimodal data at-scale, closes the first tranche of USD 8m Series B Financing to advance its AI platform alongside.
MegaCAD GmbH acquires Bausoft Informatik AG, a leading Swiss software manufacturer for building engineering services.
The founders of Santis Pharma, a Franco-Swiss laboratory company developing and marketing food supplements with health benefits, have entered into a partnership with Abenex, a French private equity investor.
Genedata AG (“Genedata”), a leading provider of software solutions for biopharmaceutical research and development, has been acquired by Danaher Corporation (NYSE: DHR) (“Danaher”), a leading global innovator in life sciences and diagnostics.
FIT Voltaira Group, a leading supplier of sensor, connectivity, and electrification solutions, announced the acquisition of the globally operating Auto-Kabel Group, a pioneer in e-mobility.
Tybourne Capital Management, a global, growth-oriented, fundamental equity investor in public and private markets, recently participated in SkyCell AG's USD 116m Series D financing round.
The owner family has agreed to sell the monitoring solutions business of Berlinger & Co. AG to Sensitech Inc. (Carrier Global Incorporation). The transaction is expected to be closed in the third quarter of 2024.
The shareholders of gammaRenax AG have sold their company to ISS Facility Services AG. gammaRenax is an efficient quality provider of integrated facility services with 1'800 employees at 16 locations in all regions of Switzerland.
BID Equity acquires Realview AG, which develops and distributes software for the Swiss construction industry.
Memo Therapeutics AG, a late-stage biotech company developing a best-in-class BKV-neutralizing anti-body for BKV infection in kidney transplantation, raised CHF 20m as part of an extension of its series C financing round.
Displaying results 1 to 10 out of 178
